News – Page 513
-
News
Graphene scoops the physics Nobel
Andre Geim and Kostya Novoselov are this year's winners for discovering that peeling sticky tape from graphite could produce an amazing new material
-
News
US concerns about rare earths scarcity gain momentum
Legislation to free America from dependence on China's rare earth minerals easily passes through House of Representatives
-
News
Glowing glucose tracker goes skin deep
Researchers develop wireless, fluorescent microbeads to sit under the skin and monitor blood glucose levels
-
News
ECHA to go easy on 'exceptional cases'
Some firms will be allowed to miss the submission deadline for Europe-wide chemicals legislation
-
News
DNA origami with a twist
Researchers in the US have designed and synthesised a nanoscale Möbius strip out of DNA origami
-
News
On-off catalyst mimics enzyme function
An enzyme-like catalyst that could form the basis for 'synthetic PCR'
-
News
Bacteria factories for Taxol precursors
E. coli bacteria have been engineered to produce precursors of one of the most widely used cancer drugs
-
News
Weightlifting crystals
Two-component crystal can bend like human muscle to lift weights 600 times greater than its own when exposed to UV light
-
News
Protein folding: knotted or not
New computational studies could help scientists unpick the knots in real proteins
-
News
US university's scheme to rate faculty draws fire
Professors unnerved by internal plan to generate profit-loss statements for faculty
-
News
Helium nanodroplets host ion analysis
New infrared spectroscopy technique uses freezing helium to provide detailed structural information of molecular ions
-
Business
Business roundup: October 2010
Sanofi bid too low says Genzyme Source: © SANOFI AVENTIS Christopher Viehbacher: ’offer provides immediate and certain value Sanofi-Aventis is not being bashful about its designs on Genzyme any longer. The French pharma giant has offered $69 (£45) per share in an all-cash bid that values the ...
-
News
America's scientific lead remains on the brink
Despite investment, the outlook for US competitiveness has deteriorated over the last five years, says influential report
-
News
Structure dictates glycan story
Small structural differences in oligosaccharide clusters can lead to dramatic differences in the way they interact with the body
-
News
End of the road for Avandia?
Risk of cardiac side effects finally causes GlaxoSmithKline's troubled diabetes drug to be pulled from European markets and severely restricted in the US
-
News
Challenging aqua regia's throne
US researchers discover 'organic' aqua regia that can selectively dissolve noble metals in solution
-
News
UK faces scientific exodus
Heads of top universities warn that researchers will abandon the UK if cuts to science funding go ahead
-
News
Catalyst improves prospects for fuel cells
Alkali ions on platinum make for a more viable water-gas shift reaction
-
News
Salmonella's secret weapon
US researchers have explained the chemical trick behind Salmonella bacteria's ability to outgrow other microbes living in the gut
-
News
Warming worry shades ozone success
CFC replacements may have helped repair the hole in the ozone layer, but could contribute significantly to climate change